{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:05:50Z","timestamp":1792026350163,"version":"4.4.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The gut microbiota and bile acids co-regulate host metabolism through bidirectional interactions. This interaction critically influences the pathogenesis and progression of cardio-metabolic diseases (CMDs), which include diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), and cardiovascular diseases. Growing evidence establishes bile acid metabolism as fundamental to the pathogenesis of CMDs. Bile acids activate both the nuclear receptor FXR and the membrane receptor TGR5, which in turn influence glucose and lipid metabolism, modulate inflammatory processes, and affect vascular functions. These signaling pathways collectively link metabolic and immune networks within the cardio-metabolic axis. This review provides an integrative overview of recent findings in bile acid signaling and its cross-talk with metabolic and immune pathways in CMDs. It critically evaluates disease mechanisms, discusses therapeutic candidates targeting bile acid pathways, and highlights future directions for the precise management of metabolic-immune disorders.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1689026","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:35:28Z","timestamp":1765953328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Bile acid\u2013microbiota interactions in cardiometabolic diseases: mechanisms and emerging therapeutic approaches"],"prefix":"10.3389","volume":"16","author":[{"given":"Feiyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3978\/j.issn.2305-5839.2014.12.06","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2019.04.009","article-title":"Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue","volume":"144","author":"Arag\u00f3n-Herrera","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/nyas.70014","article-title":"Bile acid modulation of host immunity","volume":"1551","author":"Bao-Anh","year":"2025","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.livres.2021.08.003","article-title":"Bile acid activated receptors: integrating immune and metabolic regulation in non-alcoholic fatty liver disease","volume":"5","author":"Biagioli","year":"2021","journal-title":"Liver Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0217","DOI":"10.1097\/HC9.0000000000000217","article-title":"Bile acids promote the development of HCC by activating inflammasome","volume":"7","author":"Chen","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000450981","article-title":"Intestinal Farnesoid X receptor and Takeda G protein couple receptor 5 signaling in metabolic regulation","volume":"35","author":"Chiang","year":"2017","journal-title":"Dig. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2020.07.034","article-title":"Bile acid transporter-mediated oral drug delivery","volume":"327","author":"Deng","year":"2020","journal-title":"J. Control. Release"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1513541","DOI":"10.3389\/fmicb.2025.1513541","article-title":"New insights into microbial bile salt hydrolases: from physiological roles to potential applications","volume":"16","author":"Dong","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1113\/JP279047","article-title":"TRPM2-mediated extracellular Ca2+ entry promotes acinar cell necrosis in biliary acute pancreatitis","volume":"598","author":"Fanczal","year":"2020","journal-title":"J. Physiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.livres.2025.01.005","article-title":"Bile acids and their receptors in hepatic immunity","volume":"9","author":"Fiorucci","year":"2025","journal-title":"Liver Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2019.04.008","article-title":"Advances in understanding the regulatory mechanism of cholesterol 7\u03b1-hydroxylase","volume":"164","author":"Ge","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref001","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1042\/CS20240940","article-title":"New discoveries in bile acids, gut microbiota and host interactions in health and diseases","volume":"138","author":"Gillard","year":"2024","journal-title":"Clin Sci (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control Th17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.3390\/ijms26052242","article-title":"Role of gut microbial metabolites in ischemic and non-ischemic heart failure","volume":"26","author":"Hatamnejad","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.015","article-title":"The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity","author":"He","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1234567","DOI":"10.3389\/fimmu.2025.1234567","article-title":"Modulation of immune cell differentiation by bile acid metabolites via nuclear receptor pathways","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1080\/07391102.2023.2224886","article-title":"Proanthocyanidin B2 derived metabolites may be ligands for bile acid receptors S1PR2, PXR and CAR: an in silico approach","volume":"42","author":"Hoang","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/hep.23002","article-title":"The enterohepatic circulation of bile acids in mammals: pharmacological and toxicological implications","volume":"50","author":"Hofmann","year":"2009","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2567.2012.03554.x","article-title":"Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway","volume":"136","author":"Ichikawa","year":"2012","journal-title":"Immunology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","article-title":"Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR","volume":"9","author":"Jadhav","year":"2018","journal-title":"Mol. Metab."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/jcmm.14195","article-title":"The role of intestinal microbiota in cardiovascular disease","volume":"23","author":"Jin","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2024.03.14.584471","DOI":"10.1101\/2024.03.14.584471","article-title":"Enhanced mucosal mitochondrial function corrects dysbiosis and OXPHOS metabolism in IBD","author":"Kapur","year":"2024","journal-title":"bioRxiv"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile acid signaling in metabolic and inflammatory diseases and drug development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cmet.2022.01.019","article-title":"Mitochondrial reactive oxygen species regulate epigenetic remodeling in Treg cell development mediated by bile acid isoforms","volume":"34","author":"Li","year":"2022","journal-title":"Cell Metab."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"619207","DOI":"10.1155\/2013\/619207","article-title":"Regulation of DDAH1 as a potential therapeutic target for treating cardiovascular diseases","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2217\/fca-2023-0068","article-title":"From the inside out: understanding the gut-heart connection","volume":"19","author":"Mahajan","year":"2023","journal-title":"Futur. Cardiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/gutjnl-2021-326541","article-title":"6\u03b1-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice","volume":"72","author":"Makki","year":"2023","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1038\/s41598-021-88493-0","article-title":"Discovery, optimization, and evaluation of non-bile acid FXR\/TGR5 dual agonists","volume":"11","author":"Miyata","year":"2021","journal-title":"Sci. Rep."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-025-01118-2","article-title":"FXR crosstalk with other nuclear receptors","author":"Mohammed","year":"2025","journal-title":"J. Physiol. Biochem."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/nano8020084","article-title":"Nanotherapeutics containing lithocholic acid-based amphiphilic scorpion-like macromolecules reduce in vitro inflammation in macrophages: implications for atherosclerosis","volume":"8","author":"Moretti","year":"2018","journal-title":"Nanomaterials (Basel)"},{"key":"ref002","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2015.08.012","article-title":"Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses","volume":"242","author":"Navratil","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11011-025-01542-9","article-title":"The effects of ursodeoxycholic acid on Parkinson\u2019s disease, a mechanistic review of the recent evidence","volume":"40","author":"Razavi","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/08820139.2018.1467927","article-title":"Vildagliptin recruits regulatory T cells in patients undergoing primary percutaneous coronary intervention","volume":"47","author":"Rizk","year":"2018","journal-title":"Immunol. Investig."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jhep.2014.11.020","article-title":"24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis","volume":"62","author":"Sombetzki","year":"2015","journal-title":"J. Hepatol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1530\/EJE-20-1410","article-title":"MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases","volume":"184","author":"Sonne","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11274-025-04395-7","article-title":"The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health","volume":"41","author":"Tyagi","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S2213-8587(16)30155-3","article-title":"Clinical relevance of the bile acid receptor TGR5 in metabolism","volume":"5","author":"Van Nierop","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"123456","DOI":"10.3389\/fimmu.2025.123456","article-title":"Gut microbiota-mediated bile acid metabolism and its impact on host immunity in cardiometabolic diseases","volume":"16","author":"Varanasi","year":"2025","journal-title":"Front. Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids - clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/CS20240940","article-title":"TGR5 signaling in metabolic regulation and disease","volume":"138","author":"Wang","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.28712","article-title":"Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice","volume":"64","author":"Xu","year":"2016","journal-title":"Hepatology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/imm.13672","article-title":"Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment","volume":"170","author":"Zhang","year":"2023","journal-title":"Immunology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2481418","article-title":"Deoxycholic acid-mediated Sphingosine-1-phosphate receptor 2 signaling exacerbates DSS-induced colitis through promoting Cathepsin B release","volume":"2018","author":"Zhao","year":"2018","journal-title":"J Immunol Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.3390\/ijms26094023","article-title":"Research Progress on the mechanism of bile acids and their receptors in depression","volume":"26","author":"Zhao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/ajt.16327","article-title":"TGR5\/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury","volume":"21","author":"Zhou","year":"2021","journal-title":"Am. J. Transplant."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1689026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:35:33Z","timestamp":1765953333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1689026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":53,"alternative-id":["10.3389\/fmicb.2025.1689026"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1689026","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1689026"}}